-
-
-
-
-
-
-
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
-
-
-
-
-
-
-
Virax Biolabs receives ISO quality certifications for diagnostic development
-
-
-
-
-
-
-
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
-
-
-
-
-
-
-
Virax Biolabs receives NASDAQ deficiency notice for minimum bid price
-
-
-
-
-
-
-
Virax Biolabs Group (VRAX) Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy
-
-
-
-
-
-
-
Virax Biolabs to Participate at ESCMID Global 2024
-
-
-
-
-
-
-
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar
-
1,224,181 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

